CMS frees up $275 million for state coordinated care initiatives

States eager to test payment reform models for federal health programs can apply for awards totaling $275 million, courtesy of the Centers for Medicare & Medicaid Services.

With funding authorized by the Affordable Care Act, Center for Medicare and Medicaid Innovation will provide $225 million for Model Testing Awards to help selected states design and test multipayer systems that include commercial, employee sponsored and public health plans. Arizona's Mercy Care Plan is one example of this model.

CMS is devoting another $50 million for 25 states who apply for Model Design Awards. The awards will help supplement existing programs currently in operation, such as accountable care organizations.

Long-term care facilities stand to benefit from such initiatives as they rely partly on partnerships between acute and post-acute providers that work together to lower costs, and coordinate care for dually eligible Medicare and Medicaid beneficiaries. However, a recent study expressed concern programs targeting hospital readmissions may make outcomes worse for seniors.

More in News

Experts tell lawmakers: Obama Medicare proposals would hurt long-term care — or maybe not

Experts tell lawmakers: Obama Medicare proposals would hurt ...

U.S. lawmakers heard mixed messages at a hearing Tuesday on how proposed Medicare cost-sharing reforms would impact long-term care. The House Ways and Means Subcommittee on Health focused in particular ...

Nursing home administrators can rise to 'unrealistic expectations' with disaster management, expert ...

One day after a powerful tornado destroyed a hospital and devastated an Oklahoma town, long-term care stakeholders gathered at a disaster preparedness conference organized by the Center for Preparedness Education, a joint endeavor of the Creighton University School of Medicine and the University of Nebraska ...

Long-term care physicians respond to report on antipsychotic over-prescribing

The top professional association of long-term care physicians and medical directors has reiterated its commitment to reducing the use of antipsychotics for dementia care. It did so Tuesday, in response to a recent report that criticized prescribing practices.